Men­tal health-fo­cused atai chops 30% of staff to 'fur­ther fo­cus' on loom­ing read­outs

Chop­ping the pipeline and dis­con­tin­u­ing fund­ing for cer­tain pro­grams were not enough to keep atai Life Sci­ences’ fi­nances in check af­ter all.

More than half a year af­ter an­nounc­ing those changes, the com­pa­ny has tak­en an­oth­er long look at its pipeline of drugs for men­tal health dis­or­ders and laid off 30% of its staffers. The lay­offs will main­ly im­pact those in gen­er­al and ad­min­is­tra­tion and non-clin­i­cal de­vel­op­ment roles, atai added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER